(Q54106629)

24 May 2018

title

Response to inhaled nitric oxide in patients with acute right heart syndrome. (English)

1 reference

24 May 2018

0 references

Bhorade S

1

1 reference

24 May 2018

Christenson J

2

1 reference

24 May 2018

O'connor M

3

1 reference

24 May 2018

Lavoie A

4

1 reference

24 May 2018

Pohlman A

5

1 reference

24 May 2018

Hall JB

6

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

24 May 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

24 May 2018

volume

159

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

571-579

1 reference

24 May 2018

Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Prostacyclin and right ventricular function in patients with pulmonary hypertension associated with ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Hemodynamics of volume loading compared with dobutamine in severe right ventricular infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Pulmonary vascular pressure-flow characteristics. Effects of dopamine before and after pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Nitric oxide: a physiologic messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Hemodynamic effects of inhaled nitric oxide in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.159.2.9804127

10.1164/AJRCCM.159.2.9804127

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

9927375

1 reference

24 May 2018